Among the 12 relapsed patients in the placebo group, 10 (83%) had GPA, 2 (17%) had MPA, 6 were having their first relapse, and all had ANCA positivity (10 PR3-ANCA, 2 MPO-ANCA positivity). The gene discussed is PRTN3; the disease is granulomatosis with polyangiitis.